NMR in Medicine
A special issue of Diagnostics (ISSN 2075-4418).
Deadline for manuscript submissions: closed (30 May 2015) | Viewed by 30358
Special Issue Editor
Interests: radiotracers; drug discovery; drug development; biomarkers; end point; therapeutic effect; drug efficacy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Magnetic Resonance Imaging (MRI) has become a routine technique in diagnostics imaging. Millions of MRI procedures are performed every year. It is a safe, non-invasive, and non-destructive tool for imaging soft tissues and for detecting tumors in many organs. Significant progress has been made since the first demonstration of the MRI in the 1970’s; increasingly sophisticated instrumentations and T1 and T2 MRI contrast agents (CAs) have been developed. For example, numerous CAs have become available commercially since the introduction of the first gadolinium-based MRI contrast agent in the 1980s. Subsequently, gadolinium-based CAs have become the subject of a black-box warning from the US FDA. This was due to reported serious side effects, termed Nephrogenic Systemic Fibrosis (NSF), in patients with impaired renal functions. Therefore, recent research has been focused on the development of a newer generation of MRI contrast agents with greater efficiency (high relaxivity), and increased safety (i.e., no loss of gadolinium in vivo) and targeting capability; these developments include several nanoparticle-based technologies.
Hybrid technologies involving PET/CT and SPECT/CT are being used routinely in the clinic with many thousands of scanners being used worldwide, while PET/MR imaging has been recently approved for clinical use. This encourages researchers to investigate the further development of SPECT/MR based technology. This Special Issue will provide a forum for communication among chemists, physicists, biologists, biochemists, and medical practitioners, such a radiologists. The issue will focus on research and review articles related to developments in MRI technologies, novel MRI contrast agents, clinical applications, and pharmacovigilance.
Dr. Krishan Kumar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Nuclear Magnetic Resonance, NMR
- NMR in Biomedicine
- Magnetic Resonance Imaging, MRI
- Contrast Agents
- MRI Contrast Agents
- Enhanced Relaxivity
- T1 Agents, T2 Agents
- Nanoparticulate-Based MRI Contrast Agents
- PET/MR, SPECT/MR
- Nephrogenic Systemic Fibrosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.